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study of 460,938 cases in Beijing, China
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Abstract
Background: Evidence focused on exposure to ambient carbon monoxide (CO) and the risk of hospitalizations for
cardiovascular diseases (CVD) is lacking in developing countries. This study aimed to examine the effect of CO
exposure on hospitalizations for CVD in Beijing, China.
Methods: A total of 460,938 hospitalizations for cardiovascular diseases were obtained from electronic
hospitalization summary reports from 2013 to 2017. A time-stratified case-crossover design was conducted to
investigate the association between CO exposure and hospitalizations for total and cause-specific CVD, including
coronary heart disease (CHD), atrial fibrillation (AF), and heart failure (HF). Stratified analysis was also conducted by
age group (18–64 years and ≥ 65 years) and sex.
Results: Linear exposure-response curves for the association between ambient CO exposure and hospitalizations
for CVD was observed. Ambient CO was positively associated with hospitalizations for total CVD and CHD. However,
the observed increased risk was not statistically significant for hospitalizations for AF and HF. The strongest effect of
CO concentration was observed on the current- and previous-day of exposure (lag 0–1 day). For a 1 mg/m
3 increase
in a 2-day moving average CO concentration, an increase of 2.8% [95% confidence interval (CI): 2.2 to 3.3%] and
3.0% (95% CI: 2.4 to 3.6%) in daily hospital admissions for CVD and CHD were estimated, respectively. This
association was robust after adjusting for other copollutants and did not vary by age group and sex.
Conclusions: Ambient CO exposure increased the risk of hospitalizations for CVD, especially for CHD in Beijing.
Further studies are warranted to explore the association between ambient CO and hospitalizations for AF and HF.
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Introduction
Cardiovascular disease (CVD) is a leading cause of morbid-
ity and mortality worldwide [1]. In China, approximately
29.8 million deaths in rural areas and 26.5 million deaths in
urban areas were caused by CVD in 2015 [2]. Meta-analysis
and epidemiological studies have reported that air pollution
increased the risk of morbidity and mortality due to CVD
[3–7]. Recently, Liu and colleagues conducted a nationwide
time-series analysis in 272 major cities in China and found
that ambient carbon monoxide (CO) exposure caused a
1.1% (95% confidence interval: 0.4 to 1.8%) increase in the
risk of cardiovascular disease mortality per 1mg/m3 incre-
ment [7]. However, the adverse effects of ambient CO on
hospital admissions for cardiovascular disease has not been
well described and the results were inconsistent across
studies [7–12]. For example, Koken, et al. reported a signifi-
cant association between short-term exposure to ambient
CO and hospitalizations for CVD among elderly individuals
in Denver [8]. However, this association between ambient
CO and hospitalizations for CVD outcomes was found to
be statistically insignificant by the Myocardial Ischemia Na-
tional Audit Project [12].
In many large cities such as Beijing, the capital of
China, traffic-related pollution has become a serious
environmental problem. The total number of motor vehi-
cles on the road in Beijing was nearly 5.64 million in 2017.
Approximately 80% of ambient CO was attributed to ex-
haust emissions from motor vehicles. Ambient CO is a col-
orless, odorless and nonirritating gas pollutant. The adverse
health effects of ambient CO exposure on cardiovascular
mortality has been reported in multi-city analyses in China
[7, 13]. To the best of our knowledge, only one multi-city
study conducted in China examined the short-term effects
of ambient CO on CVD hospital admissions [14]. This
study showed that a 1mg/m3 increase in CO concentra-
tions was associated with a 4.4% increase in CVD hospital
admissions [14]. However, the short-term effects of ambi-
ent CO exposure on cause-specific CVD hospitalizations
in China remain unknown. Additionally, this association
on the city-specific level has not comprehensively re-
ported, especially in large cities, such as Beijing.
In this study, we aimed to examine the associations
between ambient CO and total and cause-specific CVD
hospital admissions in Beijing. We also investigated the
robustness of this association after controlling for fine
particulate matter, sulfur dioxide, nitrogen dioxide, and
ozone. Stratified analyses by sex and age were further
conducted to explore the associations in these suscep-
tible subpopulations.
Methods
Health outcome data
CVD hospital admission records were extracted from
the Beijing Municipal Commission of Health and Family
Planning Information Center (http://www.phic.org.cn/)
between Jan 1, 2013, and Dec 31, 2017. The geographic
locations of hospitals in this study are shown in Fig. 1.
From each hospital admission record, we extracted in-
formation on the patient’s date of hospital admission,
principal diagnosis, age, and sex. Cause-specific CVD
hospitalizations were identified based on the primary
diagnosis according to the following International Clas-
sification of Diseases, 10th Revision (ICD-10) codes:
coronary heart disease (ICD-10: I20-I25, CHD), atrial
Fig. 1 The locations of the air quality monitoring stations and hospitals
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fibrillation (ICD-10: I48, AF) and heart failure (ICD-10:
I50, HF). In this study, total CVD admissions were cal-
culated as the sum of CHD, AF and HF. Because few
hospital admissions for CVD under the age of 18 years
were recorded; thus, these individuals were excluded
from the current analysis.
The Institutional Review Board at the Capital Medical
University approved the study’s protocol (IRB00009511).
Informed consent was waived as the data were typically
used for administrative purposes. Only aggregated data
was used for the current analysis.
Air pollution and meteorological data
We obtained air pollution data between Jan 1, 2013, and
Dec 31, 2017, from the Beijing Municipal Environmental
Protection Bureau (http://www.bjepb.gov.cn/), which
provided hourly monitoring data from 35 fixed-site air
quality monitoring stations covering nearly every district
(county level) in Beijing. The locations of monitoring
stations are also shown in Fig. 1. The 24-h average
concentrations of five pollutants, including carbon mon-
oxide (CO), particulate matter less than 2.5 μm in aero-
dynamic diameter (PM2.5), sulfur dioxide (SO2), nitrogen
dioxide (NO2) and daily maximum 8-h average ozone
concentrations (O3) were used in this study. Moreover,
to adjust for the potential confounding effects of weather
conditions, meteorological data including the daily mean
temperature, mean air pressure, and mean relative
humidity were extracted for the same study period from
the China Meteorological Data Sharing Service System
(https://data.cma.cn/en).
Study design
The case-crossover design [15, 16], which was first
introduced by Maclure [17], is increasingly used in the
literature to explore the short-term effects of air pollu-
tant exposure on the risk of acute events [12, 18, 19].
In this study, a time-stratified case-crossover study
design was used to compare each patient’s ambient CO
exposure on the day of hospital admission for CVD
(“case” day) to exposure on 3 or 4 reference days occur-
ring on the same day of week in the same calendar
month and year (“control” days). With this design, each
stratum consisted of one case on the case day and sev-
eral references on the control days; thus, biases due to
long-term time trends and seasonal variations can be
avoided [20]. Additionally, since individual patients
serve as their own controls, individual characteristics
(such as age, sex, marital status, education, etc.) are
also well controlled [15].
Statistical analysis
Conditional logistic regression is the standard statistical
approach in the case-crossover analysis [21]. From
statistical perspective, case-crossover design using a con-
ditional logistic regression is a merely special case of
time-series analysis [16, 22]. Typically, a stratum variable
will be defined by including one case and all other refer-
ents as if a matched case-control study. Thus, if there
are relatively large number of referents for each case, or
if there are multiple cases on the same day, the stratum
data must be expanded and repeated as many times in
order to be modelled by conditional logistic regression,
which is computationally inefficient. To minimize com-
putational complications, we applied a conditional Pois-
son regression model which has been proven to give
equivalent estimates as the conditional logistic model
but allowing for over-dispersion and auto-correlation
[23]. Conditional Poisson regression model is increas-
ingly used for case-crossover analysis in environmental
epidemiology [19, 23–25].
As mentioned previously, we first defined a stratum
variable as a combination of the year, month and day of
week, which was used to match a case and controls by
the day of the week in the same calendar month. This
variable can be used to control for time-dependent con-
founders (e.g., long-term trend, seasonality). Addition-
ally, we controlled for weather conditions by including
4-day moving average of temperature (lag 0–3), the same
day of air pressure and relative humidity (lag 0) as
covariates for the model fit based on a prior study [18].
Considering that a nonlinear relationship had been
shown between temperature, air pressure, relative hu-
midity and hospitalizations for CVD in the previous
studies [7, 19, 26], a natural cubic spline with three de-
grees of freedom (df ) was used for each weather condi-
tion variable. Public holidays (except on Saturdays and
Sundays) were regarded as a binary variable (yes or no)
and adjusted in the model [4]. Thus, in the current ana-
lysis, the conditional Poisson regression model has the
form:
Y t∼Poisson μtð Þ
Log μtð Þ ¼ aþ βCO t;lð Þ
þ ns temperature t;l¼0−3ð Þ; df ¼ 3
 
þ ns pressure t;l¼0ð Þ; df ¼ 3
 
þ ns relative humidity t;l¼0ð Þ; df ¼ 3
 
þ λStratumt þ υHolidayt
where Yt is the observed daily CVD hospital admissions
count on day t; μt is the expected daily CVD hospital ad-
missions count on day t; l is the lag of the day; β is the
coefficient for CO concentration on different lag days;
ns(…) is the natural cubic spline; df is the degrees of
freedom; λ is the coefficient for stratum that combines
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year, month and day of week; υ is the coefficient for pub-
lic holidays.
We first conducted a single-pollutant model to esti-
mate the linear effect of ambient CO on CVD hospital
admissions using different lag patterns. The single-day
effect of ambient CO was calculated on the same day
(lag 0) and up to the previous 5 days (from lag 1 to lag 5).
The cumulative delay effect was calculated as the mov-
ing average of concentrations from the same day to the
previous 1 days (lag 0–1), to the previous 3 days (lag 0–3)
and to the previous 5 days (lag 0–5). According to the
previous studies [7, 10, 27], the 2-day moving average
concentrations of CO (lag 0–1) often produced the lar-
gest estimate effects on CVD morbidity and mortality
[7]; therefore, we mainly reported the estimates effect at
lag 0–1. We further plotted exposure-response associ-
ation curves using the nature cubic spline with three df
for the concentrations of CO (lag 0–1) [13]. The nonlin-
ear association was examined by the Wald-test [28].
We also performed multipollutant models as sensitiv-
ity analyses to evaluate the robustness of our results. To
remove the impact of collinearity between CO and other
air pollutants (PM2.5, SO2, NO2, O3), principal compo-
nent analysis (PCA) was used to establish the models
[29]. We first substituted all original air pollutants by a
composite latent variable (a linear combination of all
air pollutants) through PCA, and then included this la-
tent variable in conditional Poisson regression model.
Meanwhile, the coefficient β′ of this latent variable was
transformed into the coefficient β of the original air
pollutants [30].
The potential effect modification on the association
between ambient CO (lag 0–1) and hospital admission
for CVD was examined. First, subgroup analyses strati-
fied by demographic characteristics (age group: 18–64
and ≥ 65 years; sex: male and female) were conducted in
the single-pollutant model. A Z value was calculated to
test the statistical significance of subgroups differences
as follows: Z ¼ ðβ1−β2Þ=
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SE21 þ SE22
q
, where β1 and β2
were the effect estimates for the two categories (e.g.,
male and female) and SE1 and SE2 were their respective
corresponding standard errors [11, 31]. Finally, a P value
was obtained from the standard normal distribution
based on the Z value [31].
The relative risk (RR) was calculated from the condi-
tional Poisson regression model (RR = eβ). We reported
the percentage changes (PC% = [RR-1] × 100%) in daily
hospital admissions for CVD per 1mg/m3 increase of
CO concentrations and its corresponding 95% confi-
dence interval (CI). All analyses were performed using
Stata 14 (StataCorp., College Station, Texas), with the
“xtpoisson” command to fit the conditional Poisson re-
gression, “mkspline” command to build the nature cubic
spline, “pca” command to conduct PAC, and “testparm”
commend to perform the Wald-test. P value < 0.05 was
deemed statistically significant.
Results
We included 460,938 hospital admissions for CVD, in-
cluding 378,090 CHD cases, 24,455 AF cases and 58,393
HF cases, during the 5-year study period in Beijing. Of
those, 54.9% were males, and 37.6% were under 65 years
of age. Table 1 shows the descriptive statistics of the
daily hospital admissions (counts per day) for total and
cause-specific CVD, air pollution concentrations, and
weather conditions. On average, there were 252 hospital
admissions for CVD per day, with a maximum of 749
admissions in a single day during the study period.
The daily 24-h mean CO concentration in Beijing was
1.2 mg/m3 (SD: 1.0; range: 0.0–8.0). During the study
period, the daily 24-h mean pollution concentration was
76.9 μg/m3 for PM2.5, 15.3 μg/m
3 for SO2, and 49.7 μg/m
3
for NO2, and the 8-h maximum mean concentration for
O3 was 95.7 μg/m
3. The daily mean ambient temperature
was 13.9 °C, relative humidity was 24.4% and air pressure
was 1016.7 hPa (Table 1).
The pairwise correlation among different air pollu-
tion concentrations and weather conditions during the
study period is provided in Table 2. There were strong
positive to moderate correlations between CO and
PM2.5 (Pearson’s, r = 0.830), NO2 (r = 0.820) as well as
SO2 (r = 0.670), but the correlation between CO and
O3 was negative and weak (r = − 0.379). Additionally,
the correlations between CO and each weather condi-
tion were relatively weak.
Fig. 2 shows the effects of CO exposure (1 mg/m3 in-
crement) with varying lag patterns on the percentage
change of daily hospital admission for CVD, CHD, AF
and HF. The effect of ambient CO gradually decreased
from lag 0 to lag 5 day. We found that ambient CO was
positively and significantly associated with the percent-
age change in daily hospital admissions for CVD at lag 0
and lag 1 day, but negative and significant associations
were observed at lag 4 and lag 5 day. The largest effect
was observed on lag 0–1 day. Therefore, the following
analyses only focused on the cumulative delay effects of
CO on lag 0–1 day. The lag patterns for CHD were consist-
ent with CVD. These associations between CO exposure
and AF as well as HF, however, were not significantly de-
tected on any lag day (all P > 0.05).
Figure 3 shows the exposure-response association
curve between ambient CO concentrations on lag 0–1
day and daily hospitalizations for total and cause-specific
CVD. We did not find any apparent nonlinear
exposure-response relationships for daily hospitalization
for CVD (Wald χ2 = 0.01, P for nonlinearity = 0.99), CHD
(Wald χ2 = 0.61, P for nonlinearity = 0.74), AF (Wald χ
2 = 0.06,
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P for nonlinearity = 0.97) or HF (Wald χ
2 = 3.05, P for nonlinear-
ity = 0.21).
Table 3 shows the cumulative delay effects (lag 0–1
day) of CO concentrations on daily hospital admissions
for total and cause-specific CVD. In the single pollutant
model, for a 1 mg/m3 increase in the 2-day moving aver-
age CO concentrations (lag 0–1), we observed significant
increases of 2.8% (95% CI: 2.2 to 3.3%) in the daily hos-
pital admission for CVD, 3.0% (95% CI: 2.4 to 3.6%) for
CHD, 1.4% (95% CI: -1.4 to 4.2%) for AF and 1.2% (− 0.4
to 2.7%) for HF. In the multipollutant models where
copollutants were adjusted by PCA, the significant asso-
ciations observed in the single-pollutant models weak-
ened but remained significant for CVD and CHD.
Additionally, a week association was observed between
ambient CO and hospital admissions for AF.
Figure 4 displays the associations between CO concen-
trations (lag 0–1 day) and hospital admission for total
and cause-specific CVD, stratified by age group, and sex.
No effect modifications were found to be significant (all
P for heterogeneity > 0.05).
Discussion
In the present study, we used a time-stratified case-
crossover design with conditional Poisson model to inves-
tigate the associations of ambient CO and hospitalizations
for CVD in Beijing from 2013 to 2017. We found that
short-term exposure to ambient CO was significantly
associated with an increased risk of hospital admissions
for CVD and CHD, but not for AF and HF. The largest
estimate effects were observed on the lag 0–1 day. Our
Table 1 Descriptive statistics for the daily hospital admissions for total and cause-specific cardiovascular disease, air pollution
concentrations, and weather conditions in Beijing, 2013–2017
Mean SD Minimum P2 5 Median P7 5 Maximum
Annual-average daily hospital admission
Cardiovascular disease 252 165 9 106 192 405 749
Coronary heart disease 207 142 2 77 159 340 632
Atrial fibrillation 13 11 0 4 10 22 53
Heart failure 32 16 0 20 29 43 90
Annual-average CO concentrations, mg/m3
1.2 1.0 0.0 0.6 0.9 1.4 8.0
Annual-average pollution concentration (μg/m3)
PM2.5 76.9 66.4 0.0 30.0 59.0 102.0 477.0
SO2 15.3 18.3 0.0 4.0 8.0 19.0 133.0
NO2 49.7 23.3 0.0 34.0 44.0 61.0 155.0
O3 95.7 63.0 0.0 49.0 80.8 136.0 366.7
Annual-average weather conditions
Mean temperature, °C 13.9 10.9 −14.1 3.1 15.3 23.9 32.6
Relative humidity, % 24.4 26.7 1.1 5.2 7.5 43.4 95.3
Air pressure, hPa 1016.7 10.3 994.1 1008.0 1016.5 1025.3 1044.4
P25 25th percentile, P75 75th percentile, CO carbon monoxide, PM2.5 particulate matter with aerodynamic diameter less than 2.5 μm, SO2 sulfur dioxide, NO2
nitrogen dioxide, O3 ozone
Table 2 Pearson correlation coefficients between air pollution concentrations and weather conditions in Beijing, 2013–2017
CO PM2.5 SO2 NO2 O3 Temperature Relative humidity
CO 1.000
PM2.5 0.830* 1.000
SO2 0.670* 0.562* 1.000
NO2 0.820* 0.786* 0.633* 1.000
O3 −0.379* − 0.149* − 0.338* − 0.383* 1.000
Temperature −0.398* − 0.183* − 0.488* − 0.354* 0.768* 1.000
Relative humidity −0.028 −0.015 − 0.277* − 0.017 0.029 0.135* 1.000
Air pressure 0.246* 0.061* 0.316* 0.221* − 0.691* − 0.875* − 0.090*
* P < 0.001
CO carbon monoxide, PM2.5 particulate matter with aerodynamic diameter less than 2.5 μm, SO2 sulfur dioxide, NO2 nitrogen dioxide, O3 ozone
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Fig. 2 Percentage change with 95% confidence interval of hospital admissions for total and cause-special cardiovascular disease associated with
a 1 mg/m3 increase in daily CO concentrations with varying lag patterns. Data are percentage changes (%) with 95% confidence intervals. Lag 0 = current
day. Lag 1 = previous 1 day. Lag 2 = previous 2 days. Lag 3 = previous 3 days. Lag 4 = previous 4 days. Lag 5 = previous 5 days. Lag 0–1 = 2-days moving
average of lag 0 - lag 1. Lag 0–3 = 4-days moving average of lag 0 - lag 4. Lag 0–5 = 6-days moving average of lag 0 - lag 5
Fig. 3 Exposure-response relationship curves for the association between hospital admissions for total and cause-special cardiovascular disease
and the 2-day moving average (lag 0–1) of carbon monoxide (CO) concentrations. The X-axis is the 2-day (lag0–1) moving average CO concentrations
(mg/m3) truncated for the 5–95% percentiles of the distribution concentrations in the figure. The Y-axis is the relative risk (RR), after adjusting for
temperature, relative humidity, air pressure, public holidays and long-term trends as well as seasonality. It is shown by the red solid line, and the blue
shadow represent the 95% confidence interval
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Table 3 Percentage changes in daily hospital admission for total and cause-specific cardiovascular disease per 1 mg/m3 increase in
2-day moving average (lag 0 − 1) concentration of carbon monoxide (CO), with and without adjustment of co-pollutants
Percentage changes (%) and 95% confidence intervals
Single pollutant model a Multipollutant models b
Cardiovascular disease 2.8 (2.2 to 3.3) 0.7 (0.5 to 0.9)
Coronary heart disease 3.0 (2.4 to 3.6) 0.8 (0.6 to 1.0)
Atrial fibrillation 1.4 (−1.4 to 4.2) 0.8 (0.1 to 1.5)
Heart failure 1.2 (−0.4 to 2.7) 0.2 (−0.3 to 0.7)
aWithout adjustment of co-pollutants
bAdjustment of co-pollutants by principal component analysis
Fig. 4 Percentage changes in daily hospital admission for total and cause-specific cardiovascular disease per 1 mg/m3 increase in 2-day moving
average (lag 0–1) concentration of carbon monoxide, stratified by sex (male and female) and age (< 65 and≥ 65 years)
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findings were robust after controlling for other pollutants
in the multipollutant models.
Increasingly, scientific evidence has indicated that out-
door CO exposure is related to CVD morbidity and
mortality [5–7, 10, 32–34]. For example, a multisite
time-series study conducted by Bell, et al. found that a 1
mg/m3 increase in the same-day daily 1-h maximum CO
was associated with a 1.0% (95% CI: 0.8 to 1.1%) increase
in the risk of CVD admissions in 126 United States
urban counties from 1999 to 2005 [10]. Barnett, et al.
conducted a case-crossover study in seven Australian
and New Zealand cities and combined the estimates
across these cities using a random-effects meta-analysis.
They found that a 0.9 mg/m3 increase in CO signifi-
cantly increased the risk of hospital admissions for
cardiovascular disease and ischemic heart disease by
2.2% (95% CI: 0.9 to 3.8%) and 2.3% (95% CI: 0.9 to
3.4%), respectively, in the elderly [33]. A study con-
ducted in Arak, Iran reported that a 1 mg/m3 increase in
CO concentrations on the same day was significantly as-
sociated with a 9.4% (95% CI: 5.1 to 14.0%) increase in
total cardiovascular hospital admissions [5]. Additionally,
the impact of ambient CO on cardiovascular outcomes
was attenuated after controlling for other pollutants. For
example, a study performed in Valencia, Spain showed
that ambient CO was significantly related to emergency
cardiovascular admissions in a single pollutant model,
but this association was dismissed after adjusting for
SO2 [32]. Similarly, in the Bell, et al’ study, this associ-
ation was attenuated after adjusting with same-day NO2
[10]. To reduce the collinearity between CO and other
pollutants, principle component analysis was conducted
in multipollutant models. PCA is a multivariate method
and has been applied in various multipollutant studies.
Our current findings were consistent with those of
previous studies exploring the association between CO
exposure and the risk of hospital admissions for CVD
after adjusting for PM2.5, NO2, SO2 and O3 [7, 14].
In China, urbanization and economic development have
greatly increased, especially in large cities such as Beijing
and Shanghai. Gaseous air pollution (CO, SO2, O3, and
NO2) has become a serious environmental problem. Am-
bient CO is primarily produced by incomplete combustion
of carbon-containing fuels. The major source of CO in
Beijing is generated from vehicle emissions. However, the
adverse health effects of CO exposure on cardiovascular
hospital admissions is understudied in China. Our findings
were supported by a recent multicity analysis conducted
in 14 large Chinese cities that reported a 0.8 mg/m3 in-
crease in CO concentrations on lag 2 day was significantly
associated with a 1.1% (95% CI: 0.4 to 1.8%) increase in
acute myocardial infarction admissions [35]. Moreover,
associations between ambient CO and cardiovascular
mortality had further been confirmed in a nationwide
time-series analysis in 272 cities in China [7] and in the
China Air Pollution and Health Effects Study (CAPES)
[13]. Our results were consistent with previous studies
performed in different Chinese cities [7, 13, 14, 35] that
reported a significant CO exposure effect on lag 0 and lag
1 day, and a maximum CO exposure effect on lag 0–1 day.
Another recent study conducted in Beijing showed similar
findings compared to our results [36]. Notably, a negative
and significant association between CO exposure and hos-
pitalizations for CVD or CHD was observed at lag 4 and
lag 5 day, which indicated a presence of “harvesting effect”
in the current analysis. Similarly, a time-series study con-
ducted in Beijing in 2009–2010 also found that ambient
CO had a negative effect on CVD mortality at lag 3 and
lag 4 day [30], which was consistent with what we ob-
served in the current study.
The exposure-response relationship was approximately
linear and there was no noticeable threshold effect below
which CO exposure had no effects on cardiovascular
hospitalizations in the current analysis, which was in ac-
cordance with other findings in previous studies [7, 13].
However, a multicity study in the 26 largest cities in
China showed a negative effect of CO exposure on total
CVD admissions observed below 1mg/m3 CO concen-
trations [14], which was also observed in our study.
Therefore, further studies are necessary to explore the
exposure-response relationship curve between CO levels
and cardiovascular admissions.
We also found that the association between short-term
CO exposure and hospital admissions varied by cause-spe-
cific CVD. The adverse effect was obvious and robust for
daily hospitalizations for CHD, but not for AF or HF.
Given the distinct differences in the underlying mecha-
nisms through which that CO exposure triggers CHD
compared with AF and HF [12, 37, 38], the impact of CO
exposure on hospitalizations for cause-specific CVD could
be substantially different. A previous meta-analysis that
included only two prior studies suggested that CO pollut-
ants were associated with an increased risk of AF [39].
The two prior studies used in the meta-analysis were
conducted in the USA [40] and the UK [12]. The differ-
ences between China and these western countries in CO
pollutants levels, weather conditions, and individual
characteristics may partially explain the different adverse
effects of ambient CO on hospitalization for AF. Addition-
ally, a systematic review and meta-analysis with 35
high-quality studies demonstrated a 3.5% (95% CI: 2.5 to
4.5%) increase in hospitalizations or mortality for HF per
1mg/m3 increment in CO concentrations [41]. However,
none of those 35 studies included in the meta-analysis
were conducted in China’s major cities [41]; thus the ef-
fects of CO pollution on hospitalizations for HF in China
are less well- described [42]. Moreover, the prevalence of
AF and HF in the Chinese population is considerably low.
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According to the China Multicenter Collaborative Study
on Cardiovascular Epidemiology, the estimated prevalence
of AF and HF in China is 1.0% [43] and 0.9% [44], respect-
ively. In our current analysis, we observed a relatively
small annual-average daily count for hospital admission
due to AF and HF is very small (Mean: 13 for AF and 32
for HF). Thus, we might not have enough statistical power
to elucidate a significant association between ambient CO
and hospital admissions for AF or HF. Nevertheless, the
exposure-response curves showed that high ambient CO
exposure increased the risk of hospital admissions for AF
and HF despite the statistical insignificance.
Identifying subpopulations who are the most susceptible
is critically important for policy-maker to promote a tar-
geted reduction in ambient CO [45]. A few studies sug-
gested that females and elderly people were vulnerable to
CO pollution-induced cardiovascular risk compared with
males and younger people [11, 46–48]. However, we did
not find any differences in these effects when stratified by
sex and age, implying that there is no convincing evidence
for susceptible subgroups for the adverse CO exposure ef-
fects in China. This was consistent with previous epi-
demiological studies conducted in China [7, 42, 49] and
UK [12]. Further studies are still warranted to evaluate
whether sex and age are effect modifiers in the association
between ambient CO and cardiovascular outcomes.
As previously shown, inhaled CO can bind to
hemoglobin and form carboxyhemoglobin which de-
creases the oxygen-carrying capacity of hemoglobin
and causes cellular hypoxia [50]. However, the concen-
tration of ambient CO is considered too low to induce
the toxic effects of CO [51]. Several plausible biological
mechanisms underlying the association between low
concentrations of ambient CO with CVD have been
proposed, including cardiac dysfunction [52, 53], sys-
temic inflammation [54, 55], oxidative stress [56, 57],
and thrombotic reaction [55]. Both animal models and
population-based cohort studies have demonstrated the
cardiotoxicity of CO [48, 52, 53]. A recent longitudinal
study confirmed that high-sensitivity C-reactive protein
increased with short-term exposure to CO among 61
patients with cardiovascular disease [55]. Fibrinogen
and D-dimer significantly also increased with ambient
CO exposure, and these biomarkers are related to
thrombotic reactions [54, 55]. Overall, the scientific evi-
dence supports that ambient CO exposure is associated
with cardiovascular risk.
Our study had several strengths. First, cardiovascular
hospital admission data were obtained from an established
monitoring system in Beijing; thus, misclassifications in
cardiovascular outcomes were less likely to occur. Second,
we explored the potential association between ambient
CO and cause-specific CVD admissions. However, the
limitations of our study also need to be noted. Similar to
other studies exploring the impact of air pollutants on
health outcomes, we need to carefully interpret and infer
the cause-effect relationship between carbon monoxide
exposure and hospitalizations for CVD due to the eco-
logical design of the present study. We also used ambient
CO data aggregated from fixed-site air quality monitoring
stations to represent individual-level exposure, so meas-
urement bias may exist.
Conclusions
Our findings have elucidated that short-term exposure to
ambient CO significantly increased the risk of hospitaliza-
tions for total CVD, especially for CHD, in Beijing. Further
study is necessary to identify the relationship between am-
bient CO and hospital admissions for AF and HF.
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